INS and type 2 diabetes mellitus: One mechanism proposes that BCAAs interfere with insulin signaling through activation of the mammalian target of rapamycin complex 1 (mTORC1) in skeletal muscle and serine phosphorylation of insulin receptor substrate 1 and 2, which promotes insulin resistance and can lead to the development of type 2 diabetes [20].